INTENSITY OF STATIN THERAPY AND CLINICAL OUTCOME AFTER ACUTE MYOCARDIAL INFARCTION FROM THE KOREAN ACUTE MYOCARDIAL INFARCTION REGISTRYThe incremental predictive value of red cell distribution width (RDW) for major adverse cardiac events (MACEs) has not been fully investigated in patients with acute ...
Objective Our objective was to examine the impact of the guidelines on the intensity of statin therapy at a large academic medical center. Methods We queried the electronic health record at the University of Pennsylvania Health System to evaluate current practice patterns at a large academic ...
ContextPrior intravascular ultrasound (IVUS) trials have demonstrated slowing or halting of atherosclerosis progression with statin therapy but have not
Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial Prior intravascular ultrasound (IVUS) trials have demonstrated slowing or halting of atherosclerosis progression with statin therapy but have not shown con... M Clearfield - 《Current Atherosclerosis...
I was surprised by the intensity of his anxiety. 我对他的极度焦虑感到吃惊。 The strike is growing in intensity. 罢工日益加剧。 The storm resumed with even greater intensity. 风暴更猛烈地再度肆虐。 权威例句 Effect of very high intensity statin therapy on regression of coronary atherosclerosis ...
After multivariable adjustment, the risk ratio (RR) for titrating to a high-intensity statin comparing patients with versus without DM was 1.01 (95% CI 0.96, 1.06). Among patients whose first statin fill post-AMI was for a low/moderate-intensity dosage, 7.5% of those with DM titrated to ...
The adjusted mean intensity rate of shocks was lower in patients on statin therapy (intensity rate ratio = 0.22; 95% confidence interval, 0.12-0.41; P < 0.001). Statin use was associated with a significantly higher probability of shock-free follow-up (odds ratio = 1.64; 95% confidence ...
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006;295(13):1556-1565. doi:10.1001/jama.295.13.jpc60002ArticlePubMedGoogle ScholarCrossref 12. Kini AS, Baber U, Kovacic JC, et al. Changes in plaque lipid ...
Statin use and other factors associated with mortality after major lower extremity amputation Low-intensity statins did not confer protection from mortality. At 1year after amputation, only 44.7% of patients were receiving appropriate statin therapy. CONCLUSIONS: AKA and BKA have historically been associ...
doi:10.1001/jama.2014.4030 Abstract Importance In phase 2 studies, evolocumab, a fully human monoclonal antibody to PCSK9, reduced LDL-C levels in patients receiving statin therapy. Objective To evaluate the efficacy and tolerability of evolocumab when used in combination with a moderate- vs high-...